Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Researchers find molecular mechanism that may be responsible for development of amyloidoses

A team of local researchers has proposed a molecular mechanism that may be responsible for the development of life-threatening diseases called amyloidoses. The best known of such diseases is Alzheimer's disease (AD), but there are many others that are receiving increased scrutiny, in part because of mounting evidence linking them to atherosclerosis and aging.

13 Nov 2015

Berkeley Lab scientists identify genetic factors that influence neurological disorders and body weight

Many neurological disorders, such as Parkinson's disease and Alzheimer's disease, are marked by impaired motor skills. In addition, growing evidence suggests there's a link between some neurodegenerative diseases and body weight. A recent NIH study, for example, found that adults who are obese or overweight at midlife may be at risk for earlier onset of Alzheimer's disease.

12 Nov 2015

Brain scans may predict possibility of recovering from coma

Brain scans of people in a coma may help predict who will regain consciousness, according to a study published in the November 11, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology. The study looked at connections between areas of the brain that play a role in regulating consciousness.

12 Nov 2015

Eight myths and truths about Alzheimer's disease

Although Alzheimer's disease (AD) impacts more than five million Americans and 15 million caregivers year-round, the nation is especially focused on the disease this month as it observes "National Alzheimer's Disease and Awareness Month."

11 Nov 2015

Review finds little evidence between alcohol consumption and PD incidence

For many years, researchers have been investigating whether there are any associations between Parkinson's disease (PD) and lifestyle choices such as smoking and coffee and alcohol consumption.

11 Nov 2015

L-DOPA drug may delay or prevent age-related macular degeneration

A drug already used safely to treat Parkinson's disease, restless leg syndrome and other movement disorders also could delay or prevent the most common cause of blindness affecting more than 9 million older Americans - age-related macular degeneration (AMD).

10 Nov 2015

UCSF scientists identify eye drop chemical that may reverse cataracts

A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).

6 Nov 2015

Estrogen-like drug may not be beneficial to women with Alzheimer's dementia

An estrogen-like drug, raloxifene, has no demonstrated benefit on memory and thinking skills for women with dementia due to Alzheimer's disease, according to a study published in the November 4, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

5 Nov 2015

Article explores viewpoints on role of mild cognitive impairment in Parkinson's disease

The current issue of Neurodegenerative Disease Management explores evolving viewpoints on the role of mild cognitive impairment in Parkinson's Disease (PD-MCI), a medical issue which currently lacks consensus. Neurodegenerative Disease Management is published by Future Science Group. The article is also available free of charge to members of Neurology Central, FSG's online community for the international neurology community.

5 Nov 2015

Unwanted formation of blood vessels in the brain may cause intractable difficulties for Parkinson's disease patients

Unwanted formation of blood vessels (angiogenesis) in the brain is likely to be the cause of intractable walking and balance difficulties for people who suffer from Parkinson's disease. This conclusion is supported by new research from Lund University in Sweden.

5 Nov 2015

Oxford professor wins Heinrich Wieland Prize for pioneering method that helps control nerve cells with light

Gero Miesenböck was the first to insert a light-controlled on/off switch into brain cells. His pioneering method allows scientists to switch nerve cells on and off selectively and observe how the behaviour of, for example, fruit flies or mice changes as a result. In this way, researchers can learn in a step-by-step process what behaviour the studied brain circuits control and what goes awry in disease. For his method, hailed as a "breakthrough of the decade," Professor Gero Miesenböck of the University of Oxford will receive the 100,000-euro Heinrich Wieland Prize of the Boehringer Ingelheim Foundation in Munich on November 6, 2015.

4 Nov 2015

Scientists propose that Alzheimer's disease should be treated separately

Deciphering the mechanism that underlies the development of Alzheimer's disease in certain families but not in others, researchers at the Hebrew University of Jerusalem's Faculty of Medicine have proposed that the malady is actually a collection of diseases that probably should be treated with a variety of different approaches.

4 Nov 2015

Charles Bonnet syndrome: an interview with Dr. Dominic ffytche

Charles Bonnet syndrome is the name we give to the visual hallucinations associated with eye disease. There are lots of different causes of visual hallucinations. Many different medical problems and medications can cause them, but, when the cause is eye disease, it's referred to as Charles Bonnet Syndrome after Charles Bonnet, who was a natural philosopher in the 18th century.

2 Nov 2015

Penn Medicine's Gordon Baltuch performs 1,000th deep brain stimulation procedure

Deep brain stimulation (DBS) improves many of the motor symptoms of Parkinson's disease (PD) and is a life-alerting surgery for many patients. Penn Medicine's Gordon Baltuch, MD, a professor of Neurosurgery and director of the Penn Center for Functional and Restorative Neurosurgery, is one of the most prolific DBS surgeons in the world, having recently performed his 1,000th procedure, marking an important milestone for Baltuch and Penn Medicine.

31 Oct 2015

Scientists identify new jelly-like properties of essential proteins that lead to serious diseases

Scientists at the University of Cambridge have identified a new property of essential proteins which, when it malfunctions, can cause the build up, or 'aggregation', of misshaped proteins and lead to serious diseases.

31 Oct 2015

FAU, Max Planck ink new agreement to recruit and retain promising scientists

Florida Atlantic University, the Max Planck Florida Institute for Neuroscience and the Max Planck Society based in Germany, have signed an innovative agreement to facilitate a research and education program that will recruit promising scientists to MPFI and FAU.

30 Oct 2015

Older women who complain of memory problems may experience thinking impairment decades later

New research suggests that older women who complain of memory problems may be at higher risk for experiencing diagnosed memory and thinking impairment decades later. The study is published in the October 28, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Oct 2015

New generation of incretin-based medicines allows coordinated action against diabesity

The new generation of incretin-based medicines will allow a coordinated action against the combination diabetes/obesity, also known as diabesity, in some cases with only a single weekly dose, and with the likelihood of additional beneficial effects on other health complications related to this condition, such as cardiovascular and neurodegenerative diseases.

28 Oct 2015

Watching too much TV increases risk of death

On average, 80% of American adults watch 3.5 hours of television per day and multiple observational studies have demonstrated a link between TV viewing and poorer health. In this new study published in the December issue of the American Journal of Preventive Medicine, investigators reported an association between increasing hours of television viewing per day and increasing risk of death from most of the major causes of death in the United States.

28 Oct 2015

Lewy Body Composite Risk Score detects LBD and Parkinson's disease dementia in three minutes

Although Lewy Body disease (LBD) is the second-most-common degenerative disease after Alzheimer's disease, it's not exactly a household name. It affects more than 1.3 million Americans, is poorly recognized, and diagnosis is often significantly delayed. Patients with LBD simultaneously experience losses in cognitive function, mobility and behavior.

27 Oct 2015

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Researchers find molecular mechanism that may be responsible for development of amyloidoses

Berkeley Lab scientists identify genetic factors that influence neurological disorders and body weight

Brain scans may predict possibility of recovering from coma

Eight myths and truths about Alzheimer's disease

Review finds little evidence between alcohol consumption and PD incidence

L-DOPA drug may delay or prevent age-related macular degeneration

UCSF scientists identify eye drop chemical that may reverse cataracts

Estrogen-like drug may not be beneficial to women with Alzheimer's dementia

Article explores viewpoints on role of mild cognitive impairment in Parkinson's disease

Unwanted formation of blood vessels in the brain may cause intractable difficulties for Parkinson's disease patients

Oxford professor wins Heinrich Wieland Prize for pioneering method that helps control nerve cells with light

Scientists propose that Alzheimer's disease should be treated separately

Charles Bonnet syndrome: an interview with Dr. Dominic ffytche

Penn Medicine's Gordon Baltuch performs 1,000th deep brain stimulation procedure

Scientists identify new jelly-like properties of essential proteins that lead to serious diseases

FAU, Max Planck ink new agreement to recruit and retain promising scientists

Older women who complain of memory problems may experience thinking impairment decades later

New generation of incretin-based medicines allows coordinated action against diabesity

Watching too much TV increases risk of death

Lewy Body Composite Risk Score detects LBD and Parkinson's disease dementia in three minutes

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in